Patents Assigned to ViaCord, LLC
  • Treatment of ischemia using stem cells
    Patent number: 8613906
    Abstract: The invention features a method for treating or preventing ischemia in a mammal by administering unrestricted somatic stem cells (USSCs) to the mammal.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: December 24, 2013
    Assignee: ViaCord, LLC
    Inventors: Andreas Muhs, Stephan Wnendt
  • METHODS OF IMPROVING CENTRAL NERVOUS SYSTEM FUNCTIONING
    Publication number: 20130142756
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Application
    Filed: November 19, 2012
    Publication date: June 6, 2013
    Applicants: The General Hospital Corporation, ViaCord, LLC
    Inventors: ViaCord, LLC, The General Hospital Corporation
  • Methods of improving central nervous system functioning
    Patent number: 8337833
    Abstract: Methods of causing an improvement in central nervous system function are provided. The methods include administering an aliquot of stem cells to the patient, the cells being derived from blood, e.g., umbilical cord blood. In some cases a growth factor is administered with the cells.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: December 25, 2012
    Assignees: The General Hospital Corp., ViaCord, LLC
    Inventors: Morey Kraus, Seth Finklestein, Paul Clark